← Back to Clinical Trials
Recruiting NCT06710002

NCT06710002 Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06710002
Status Recruiting
Phase
Sponsor Instituto Médico Tecnológico SL
Condition Menopause
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-05-05
Primary Completion 2026-03

Trial Parameters

Condition Menopause
Sponsor Instituto Médico Tecnológico SL
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age 45 Years
Max Age 65 Years
Start Date 2025-05-05
Completion 2026-03
Interventions
Pelvify: Menopause and dyspareunia treatmentFace to Face Physical Therapy ProtocolFace to Face Protocol Combined With an Asynchronous Telerehabilitation Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study is to analyze the effectiveness of a telerehabilitation program with respect to a face-to-face physiotherapy protocol in relation to the improvement of sexual function, the reduction of pain and the improvement of the quality of life, in the treatment of menopausal women with dyspareunia.

Eligibility Criteria

Inclusion Criteria: * Female * Age from 45 to 65 years. * Menopausal * Suffer dyspareunia for 3 months of evolution. * Willing to complete study questionnaires and informed consent study. Exclusion Criteria: * Pacemaker or other types of electronic implant. * Thrombophlebitis. * Skin hypersensitivity or rejection of manual contact. * Active or previous treatment with chemotherapy or radiotherapy in the pelvic area. * Wounds or burns in the pelvic area. * Allergy to nickel and chromium. * Other pelvic floor physiotherapy treatments during the study intervention. * Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention. * Surgical intervention in the pelvic area in the last 3 months. * Fibromyalgia. * Oncological processes that affect the sacrum. * Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions). * Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosi

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology